文献速递淋巴瘤

经典型霍奇金淋巴瘤微环境中高比例PD-1+和PD-L1+白细胞与较差预后相关

High proportions of PD-1+ and PD-L1+ leukocytes in classical Hodgkin lymphoma microenvironment are associated with inferior outcome.
PubMed 文献 · Blood Adv · 2017-08-08

该研究纳入丹麦和瑞典1990至2007年诊断的387例经典型霍奇金淋巴瘤患者,用免疫组化检测诊断性活检组织中PD-1、PD-L1和PD-L2阳性细胞比例,多因素分析显示微环境中高比例PD-1+白细胞(HR 1.77)和PD-L1+白细胞(HR 1.89)与较差无事件生存相关,高比例PD-L1+白细胞还与较差总生存相关(HR 3.46)。

要点

  • 微环境中高比例PD-1+白细胞与较差无事件生存相关(HR 1.77,95%CI 1.10-2.86)。
  • 微环境中高比例PD-L1+白细胞与较差无事件生存相关(HR 1.89,95%CI 1.08-3.30)。
  • 高比例PD-L1+白细胞还与较差总生存相关(HR 3.46,95%CI 1.15-10.37)。

核心结论

  • 这是首项在多因素分析后显示经典型霍奇金淋巴瘤较差结局与肿瘤微环境中高比例PD-1+和PD-L1+白细胞相关的研究。

研究设计与样本

  • 纳入丹麦和瑞典1990至2007年诊断、年龄15至86岁的经典型霍奇金淋巴瘤患者,387例有组织芯片样本。
  • 采用免疫组化检测PD-1、PD-L1和PD-L2并计算阳性细胞比例,用Cox比例风险回归分析无事件生存和总生存。

主要发现

  • 多因素分析中,微环境高比例PD-1+白细胞与较差无事件生存相关(HR 1.77;95%CI 1.10-2.86)。
  • 多因素分析中,微环境高比例PD-L1+白细胞与较差无事件生存相关(HR 1.89;95%CI 1.08-3.30)。
  • 多因素分析中,高比例PD-L1+白细胞还与较差总生存相关(HR 3.46;95%CI 1.15-10.37)。
  • 多因素分析校正了白细胞计数>15×10^9/L、血红蛋白<105 g/L、白蛋白<40 g/L、B症状、结外受累、分期、巨块型肿瘤、结节硬化型、EB病毒状态、淋巴细胞计数<0.6×10^9/L、性别和国家。

关键数值与推荐

  • 高比例PD-1+白细胞组无事件生存HR 1.77(95%CI 1.10-2.86)。
  • 高比例PD-L1+白细胞组无事件生存HR 1.89(95%CI 1.08-3.30)。
  • 高比例PD-L1+白细胞组总生存HR 3.46(95%CI 1.15-10.37)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Immune checkpoint inhibition targeting the programmed death receptor (PD)-1 pathway is a novel treatment approach in relapsed and refractory classical Hodgkin lymphoma (cHL). Identifying patients with a high risk of treatment failure could support the use of PD-1 inhibitors as front-line treatment. Our aim was to investigate the prognostic impact of PD-1, programmed death-ligand 1 (PD-L1), and PD-L2 in the tumor microenvironment in diagnostic biopsies of patients with cHL. Patients from Denmark and Sweden, diagnosed between 1990 and 2007 and ages 15 to 86 years, were included. Tissue microarray samples were available from 387 patients. Immunohistochemistry was used to detect PD-1, PD-L1, and PD-L2, and the proportions of positive cells were calculated. Event-free survival (EFS; time to treatment failure) and overall survival (OS) were analyzed using Cox proportional hazards regression. High proportions of both PD-1+ (hazard ratio [HR], 1.77; 95% confidence interval [CI], 1.10-2.86) and PD-L1+ (HR = 1.89; 95% CI, 1.08-3.30) leukocytes in the microenvironment were associated with inferior EFS in a multivariate analysis (adjusted for white blood cell count >15 × 109/L, hemoglobin <105 g/L, albumin <40 g/L, B symptoms, extranodal involvement, stage, bulky tumor, nodular sclerosis subtype, Epstein-Barr virus status, lymphocyte count <0.6 × 109/L, sex, and country). A high proportion of PD-L1+ leukocytes was also associated with inferior OS in a multivariate analysis (HR, 3.46; 95% CI, 1.15-10.37). This is the first study to show a correlation after multivariate analysis between inferior outcome in cHL and a high proportion of both PD-1+ and PD-L1+ leukocytes in the tumor microenvironment.

来源:Blood Adv,查看原文。版权归原作者所有。

引用

  1. Hollander P, Kamper P, Smedby KE, et al. High proportions of PD-1+ and PD-L1+ leukocytes in classical Hodgkin lymphoma microenvironment are associated with inferior outcome. Blood Adv. 2017. PMID: 29296784. doi:10.1182/bloodadvances.2017006346

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。